Followers | 609 |
Posts | 26743 |
Boards Moderated | 1 |
Alias Born | 08/12/2010 |
Sunday, April 15, 2018 9:57:13 PM
* I am adding this message link to the DD in the sticky.
I like what I see here and am glad to have the shares I have. Targeting BILLIONS IN REVENUE FOLKS AND THE TECHNOLOGY IS REAL AND PROVEN. AMAZING!!!
WORTHY OF A MARKET CAP 50-100 MILLION TODAY THATS A PPS .104 - .208!
Fellow investors it looks to me like management has been busy getting their ducks in a row. Cleaning up notes and debt. Using restricted shares and the CEO himself adding a huge chunk. We see almost 30% shares held by insiders.
Are they preparing for something much larger here. I still believe A 2018 BUY OUT IS IN THE WORKS!!!
The "ED" rollout continues and the WORD IS GETTING OUT with Creative Medical Technology Holdings gave the Keynote Speaker at Gathering of Health Care Innovators.
The Company's Stem Cell Therapies to be Main Subject at Dr. James Veltmeyer's Congressional Health Care Symposium.
Finalized with 8K letting us know where everything stands O/S.
TOTAL O/S: 480,035,712
(Nothingness with billions in rev's targeted via multiple diverse procedures! 20-36 Billion "ED" alone 18 Billion "MS" alone.)
INSIDER OWNERSHIP: 29.9% (143,489,101 shares)
FLOAT: 336,546,611 SHARES (This is nothingness folks)
SC 13 d/a
CREATIVE MEDICAL HEALTH INC.
sHARES 68,511,217
PERCENT OF O/S : 14.3%
TIMOTHY WARBINGTON
sHARES 74,977,884
PERCENT OF O/S : 15.6%
TOTAL PERCENT: 29.9% OF O/S INSIDERS HOLD!!!
FORM 4's:
CREATIVE MEDICAL HEALTH INC.
Purchases: 4-11-2018 9.855,290 shares at a price .0138 totaling $136,003
TIMOTHY WARBINGTON
Purchases: 4-12-2018 9,855,290 shares at a price .0138 totaling $136,003
TOTAL PURCHASE DOLLAR VALUE: $272,006
8k - Issued 4-13-2018
RECAP's the over a month of transaction:
From March 2, 2018 through April 12, 2018, we issued an aggregate of 144,585,823 shares upon the conversions of outstanding notes and 92,023,304 shares upon the cashless exercise of outstanding warrants. These conversions were made pursuant to the exemption provided by Section 3(a)(9) of the Securities Act of 1933. As a result of these issuances, we have outstanding 480,035,712 shares of common stock as of April 12, 2018.
TOTAL O/S: 480,035,712 This number matches the O/S number used to calculate the insider percentages above
Creative Medical Technology Holdings to be Keynote Speaker at Gathering of Health Care InnovatorsPress Release | 04/12/2018
** THE WORD IS GETTING OUT!!!!
Creative Medical Technology Holdings to be Keynote Speaker at Gathering of Health Care Innovators
The Company's Stem Cell Therapies to be Main Subject at Dr. James Veltmeyer's Congressional Health Care Symposium
4/12/18
https://www.otcmarkets.com/stock/CELZ/news/Creative-Medical-Technology-Holdings-to-be-Keynote-Speaker-at-Gathering-of-Health-Care-Innovators?id=189012
Shareholder Update: Creative Medical Technology Holdings, Inc. Extinguishes Additional Debt With Affiliate Company Converting To Restricted Common Shares
Excellent conversion to restricted shares at a conversion price .0138!! CREATIVE MEDICAL HEALTH INC. AFFILILIATE FORM 4 ABOVE!
4/12/18
https://www.otcmarkets.com/stock/CELZ/news/Shareholder-Update-Creative-Medical-Technology-Holdings-Inc-Extinguishes-Additional-Debt-With-Affiliate-Company-Converti?id=188995
Medical Technology Holdings Announces Superior Immune Modulatory of AmnioStem Stem Cells Compared to other Stem Cell TypesPress Release | 04/04/2018
New Data Opens Door to Addressing Multi-Billion Dollar Autoimmune Market
* We know that MS alone is an 18 billion per year target market!!!!
https://www.otcmarkets.com/stock/CELZ/news/Creative-Medical-Technology-Holdings-Announces-Superior-Immune-Modulatory-of-AmnioStem-Stem-Cells-Compared-to-other-Stem?id=188148
ALL POSTS are just my opinion! Never BUY/SELL stock based on only them! Perform your own DD and make your own decision!
Recent CELZ News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/17/2024 08:02:27 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 05/17/2024 08:01:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/10/2024 08:45:39 PM
- Creative Medical Technology Holdings Provides Corporate Update • Business Wire • 03/27/2024 01:00:00 PM
- Creative Medical Technology Holdings Inc. Announces FDA Authorization for Groundbreaking Type 1 Diabetes Prevention Therapy Under Expanded Access • Business Wire • 03/07/2024 02:15:00 PM
- Biotech Finds Mid-Week Success Following FDA Announcement • AllPennyStocks.com • 03/06/2024 09:10:00 PM
- Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy • Business Wire • 03/06/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/20/2023 09:05:37 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 11/15/2023 01:00:00 PM
- Creative Medical Technology Holdings Announces IRB Approval for FDA Cleared Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ ("CELZ-201-DDT") Novel Cell Therapy to Treat Chronic Lower Back Pain • PR Newswire (US) • 10/10/2023 12:00:00 PM
- Creative Medical Technology Holdings Receives FDA Clearance to Initiate a Phase 1/2 Clinical Trial of StemSpine® using AlloStem™ (CELZ-201-DDT) for the Treatment of Chronic Lower Back Pain • PR Newswire (US) • 09/19/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/11/2023 08:45:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/29/2023 09:37:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/28/2023 01:00:18 PM
- Creative Medical Technology Holdings Regains Compliance With Nasdaq Listing Requirements • PR Newswire (US) • 06/28/2023 12:00:00 PM
- Creative Medical Technology Announces $2 Million Share Repurchase Program • PR Newswire (US) • 06/12/2023 12:01:00 PM
- Creative Medical Technology Holdings Provides Corporate Update • PR Newswire (US) • 06/12/2023 12:00:00 PM
- Creative Medical Technology Holdings Announces Reverse Stock Split • PR Newswire (US) • 06/09/2023 04:30:00 PM
- Creative Medical Technology Holdings Announces Successful Completion of the First Phase of its Program with Greenstone Biosciences, Inc. to Develop Next Generation iPSC Pipeline for ImmCelz® Immunotherapy Platform • PR Newswire (US) • 05/31/2023 12:00:00 PM
Avant Technologies Engages Wired4Tech to Evaluate the Performance of Next Generation AI Server Technology • AVAI • May 23, 2024 8:00 AM
Branded Legacy, Inc. Unveils Collaboration with Celebrity Tattoo Artist Kat Tat for New Tattoo Aftercare Product • BLEG • May 22, 2024 8:30 AM
"Defo's Morning Briefing" Set to Debut for "GreenliteTV" • GRNL • May 21, 2024 2:28 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM